Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-183
Closed -$13.6K 655
2024
Q2
$13.6K Sell
183
-15
-8% -$1.12K ﹤0.01% 499
2024
Q1
$15.4K Buy
+198
New +$14.7K 0.01% 477
2023
Q4
Sell
-146
Closed -$10.1K 620
2023
Q3
$10.1K Buy
146
+17
+13% +$1.28K ﹤0.01% 516
2023
Q2
$10K Buy
129
+3
+2% +$245 ﹤0.01% 521
2023
Q1
$10K Hold
126
﹤0.01% 529
2022
Q4
$9K Hold
126
﹤0.01% 519
2022
Q3
$8K Sell
126
-2
-2% -$139 ﹤0.01% 541
2022
Q2
$9K Buy
128
+7
+6% +$520 ﹤0.01% 532
2022
Q1
$9K Buy
121
+54
+81% +$3.88K ﹤0.01% 569
2021
Q4
$5K Hold
67
﹤0.01% 745
2021
Q3
$5K Hold
67
﹤0.01% 733
2021
Q2
$5K Hold
67
﹤0.01% 735
2021
Q1
$5K Hold
67
﹤0.01% 726
2020
Q4
$5K Sell
67
-14
-17% -$988 ﹤0.01% 681
2020
Q3
$6K Hold
81
﹤0.01% 640
2020
Q2
$5K Hold
81
﹤0.01% 623
2020
Q1
$4K Buy
81
+46
+131% +$2.19K ﹤0.01% 660
2019
Q4
$2K Hold
35
﹤0.01% 783
2019
Q3
$2K Sell
35
-46
-57% -$2.26K ﹤0.01% 781
2019
Q2
$4K Hold
81
﹤0.01% 646
2019
Q1
$4K Hold
81
﹤0.01% 641
2018
Q4
$3K Hold
81
﹤0.01% 681
2018
Q3
$3 Hold
81
﹤0.01% 690
2018
Q2
$3 Hold
81
﹤0.01% 747
2018
Q1
$3K Hold
81
﹤0.01% 702
2017
Q4
$3K Buy
+81
New +$3.23K ﹤0.01% 610

Other funds holding HOLX

Front Row Advisors's HOLX Position: Q3 2024 in Review

Front Row Advisors sold out of Hologic (HOLX) in Q3 2024, closing a stake of 183 shares — an estimated $13.6K sold.

Front Row Advisors first reported a position in HOLX in Q4 2017 and held it in 26 quarters. The position peaked at $15.4K in Q1 2024. 726 funds tracked by Wall St. Rank hold HOLX as of Q3 2024.

  • Front Row Advisors reported no remaining Hologic position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 183 Hologic shares in Q3 2024, an estimated $13.6K.
  • Front Row Advisors first reported a position in Hologic in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Hologic position peaked at $15.4K in Q1 2024.
  • 726 funds tracked by Wall St. Rank held Hologic as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.